Newbury Park, CA, United States of America

Yuan-Hon Kiang

USPTO Granted Patents = 4 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 70(Granted Patents)

Company Filing History:

3 out of 216

Arena Pharmaceuticals, Inc.

Years Active: 2008-2015

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8980881 - [object Object] (2015-03-17),

2. 8697686 - Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-thtrahydro-1H-3-benzazepine hydrochloride (2014-04-15),

3. 8168624 - [object Object] (2012-05-01),

4. 7365202 - Polymorphs of an androgen receptor modulator (2008-04-29),

Title: The Contributions of Yuan-Hon Kiang

Introduction

Yuan-Hon Kiang is an accomplished inventor based in Rahway, NJ (US). He is currently associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. Despite having no patents to his name, his work in the pharmaceutical industry has contributed to advancements in healthcare.

Latest Patents

Yuan-Hon Kiang currently holds 4 patents. This indicates that his contributions may be more focused on research and development rather than patentable inventions.

Career Highlights

Throughout his career, Yuan-Hon Kiang has been involved in various projects at Merck Sharp & Dohme Corporation. His expertise in the field has allowed him to work on innovative solutions that aim to improve patient outcomes and enhance drug efficacy.

Collaborations

Due to space constraints, the details of his collaborations will not be included.

Conclusion

Yuan-Hon Kiang's work at Merck Sharp & Dohme Corporation highlights the importance of research and development in the pharmaceutical industry. His contributions, although not reflected in patents, play a significant role in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.